Haque, Sofia Sadia

Publications

Sort by

Co-Author Network

selected publications

Toward individualized dosimetry for radiopharmaceutical therapy in day-to-day clinical practice of nuclear oncology: overcoming heterogeneity of radiation-absorbed dose to tumor and critical organs. European journal of nuclear medicine and molecular imaging. 2023 Editorial Article GET IT
Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial. Nature medicine. 2023 Academic Article GET IT
Times cited: 8
Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma. Journal of neuro-oncology. 2023 Academic Article GET IT
Phase 1 study of intraventricular ¹³¹I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies. Journal of hematology & oncology. 2022 Academic Article GET IT
Times cited: 21
Enhancing Radioiodine Incorporation in BRAF-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical Trial. Thyroid : official journal of the American Thyroid Association. 2022 Academic Article GET IT
Times cited: 35
ADC Histogram Analysis of Pediatric Low-Grade Glioma Treated with Selumetinib: A Report from the Pediatric Brain Tumor Consortium. AJNR. American journal of neuroradiology. 2022 Academic Article GET IT
Times cited: 4
Next-generation Sequencing of Cerebrospinal Fluid for Clinical Molecular Diagnostics in Pediatric, Adolescent and Young Adult (AYA) Brain Tumor Patients. Neuro-oncology. 2022 Academic Article GET IT
Semisupervised Training of a Brain MRI Tumor Detection Model Using Mined Annotations. Radiology. 2022 Academic Article GET IT
Times cited: 8
Magnetic resonance spectroscopic imaging in gliomas: clinical diagnosis and radiotherapy planning. BJR open. 2020 Review GET IT
Times cited: 37
Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation. The Journal of clinical investigation. 2020 Academic Article GET IT
Times cited: 176
Reliability of CT myelography versus MRI in the assessment of spinal epidural disease. Clinical imaging. 2020 Academic Article GET IT
A Phase 1b Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell Carcinoma. International journal of radiation oncology, biology, physics. 2019 Academic Article GET IT
Times cited: 13
Central nervous system neuroblastoma metastases pseudoprogression following intraventricular anti-B7-H3 radioimmunotherapy. Journal of neuro-oncology. 2019 Article GET IT
Phase 2 study of vascular endothelial growth factor trap for the treatment of metastatic thyroid cancer. Cancer. 2019 Academic Article GET IT
Times cited: 7
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial. The Lancet. Oncology. 2019 Academic Article GET IT
Times cited: 345
Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers. The Journal of clinical endocrinology and metabolism. 2019 Academic Article GET IT
Times cited: 168
Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019 Academic Article GET IT
Times cited: 149
Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial. The Lancet. Oncology. 2018 Academic Article GET IT
Times cited: 197
A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Academic Article GET IT
Times cited: 39
Phase I study of induction chemotherapy with afatinib, ribavirin, and weekly carboplatin and paclitaxel for stage IVA/IVB human papillomavirus-associated oropharyngeal squamous cell cancer. Head & neck. 2017 Academic Article GET IT
Times cited: 31
A phase II study of radioimmunotherapy with intraventricular ¹³¹ I-3F8 for medulloblastoma. Pediatric blood & cancer. 2017 Academic Article GET IT
Times cited: 51
A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer. Breast cancer research : BCR. 2017 Academic Article GET IT
Times cited: 49
Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer. Cancer. 2017 Academic Article GET IT
Times cited: 57
A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors. PloS one. 2017 Academic Article GET IT
Times cited: 33
A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors. Pediatric blood & cancer. 2016 Academic Article GET IT
Times cited: 34
A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology. 2016 Academic Article GET IT
Times cited: 88
A novel magnetic resonance imaging segmentation technique for determining diffuse intrinsic pontine glioma tumor volume. Journal of neurosurgery. Pediatrics. 2016 Academic Article GET IT
Times cited: 12
Second-opinion interpretations of neuroimaging studies by oncologic neuroradiologists can help reduce errors in cancer care. Cancer. 2016 Academic Article GET IT
Times cited: 41
Conventional and Advanced Imaging of Diffuse Intrinsic Pontine Glioma. Journal of child neurology. 2016 Review GET IT
Times cited: 26
A Novel Methodology for Applying Multivoxel MR Spectroscopy to Evaluate Convection-Enhanced Drug Delivery in Diffuse Intrinsic Pontine Gliomas. AJNR. American journal of neuroradiology. 2016 Academic Article GET IT
Times cited: 4
Command hallucinations to harm self in a child with recurrent right temporal astrocytoma: a case report. Psycho-oncology. 2015 Article GET IT
Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma. Head & neck. 2015 Academic Article GET IT
Times cited: 31
A phase II study of pralatrexate with vitamin B12 and folic acid supplementation for previously treated recurrent and/or metastatic head and neck squamous cell cancer. Investigational new drugs. 2014 Academic Article GET IT
Times cited: 4
Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC). Annals of oncology : official journal of the European Society for Medical Oncology. 2014 Academic Article GET IT
Times cited: 20
A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancer. Clinical breast cancer. 2013 Academic Article GET IT
Times cited: 69
A phase 1 study of everolimus + weekly cisplatin + intensity modulated radiation therapy in head-and-neck cancer. International journal of radiation oncology, biology, physics. 2013 Academic Article GET IT
Times cited: 47
Evaluation of romidepsin for clinical activity and radioactive iodine reuptake in radioactive iodine-refractory thyroid carcinoma. Thyroid : official journal of the American Thyroid Association. 2013 Academic Article GET IT
Times cited: 60
Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. The New England journal of medicine. 2013 Academic Article GET IT
Times cited: 651
A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer. Cancer. 2013 Academic Article GET IT
Times cited: 40
A randomized phase II study of cetuximab every 2 weeks at either 500 or 750 mg/m2 for patients with recurrent or metastatic head and neck squamous cell cancer. Journal of the National Comprehensive Cancer Network : JNCCN. 2012 Academic Article GET IT
Times cited: 36
Collision in the inferior olive: hypertrophic olivary degeneration complicated by radiation necrosis in brainstem primitive neuroendocrine tumor. 2012 GET IT
Times cited: 5
A phase I study of temsirolimus plus carboplatin plus paclitaxel for patients with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC). Cancer chemotherapy and pharmacology. 2012 Academic Article GET IT
Times cited: 27
Spectrum of central nervous system abnormalities in neurocutaneous melanocytosis. Developmental medicine and child neurology. 2012 Academic Article GET IT
Times cited: 54
A phase 2 study of bevacizumab with cisplatin plus intensity-modulated radiation therapy for stage III/IVB head and neck squamous cell cancer. Cancer. 2012 Academic Article GET IT
Times cited: 57
Hemangioma of the cavernous sinus in a child. 2011 GET IT
Times cited: 3
A phase I study of daily everolimus plus low-dose weekly cisplatin for patients with advanced solid tumors. Cancer chemotherapy and pharmacology. 2011 Academic Article GET IT
Times cited: 34
Phase II study of saracatinib (AZD0530) for patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). Anticancer research. 2011 Academic Article GET IT
Times cited: 77
A phase 2 study of pemetrexed plus gemcitabine every 2 weeks for patients with recurrent or metastatic head and neck squamous cell cancer. Cancer. 2010 Academic Article GET IT
Times cited: 8
Common and unusual craniofacial manifestations of metastatic neuroblastoma. Neuroradiology. 2010 Review GET IT
Times cited: 12
Imaging of metastatic CNS neuroblastoma. AJR. American journal of roentgenology. 2010 Academic Article GET IT
Times cited: 29
Imaging of lymphoma of the central nervous system, spine, and orbit. Radiologic clinics of North America. 2008 Review GET IT
Times cited: 47
Intracranial aneurysms in infants and children. Pediatric radiology. 1998 Academic Article GET IT
Times cited: 89

more ...

less ...

Background

education and training

M.D., Emory University School of Medicine 1997
B.A., Princeton University 1993

Contact

full name

Sofia Sadia Haque

VIVO Weill Cornell Medical College

Sofia Sadia Haque Associate Professor of Clinical Radiology

Publications

selected publications

Background

education and training

Contact

full name